Skip to main content

The use of peritoneal dialysis in special situations

  • Chapter
Textbook of Peritoneal Dialysis
  • 249 Accesses

Abstract

Peritoneal dialysis (PD) is now widely and successfully used to treat end-stage renal disease (ESRD) patients. The continuous nature of the therapy and its home-based, self-care nature make it particularly advantageous for certain subgroups of patients. Using the peritoneal cavity as access provides additional uses of the therapy in both uraemic and nonuraemic states. This chapter focuses on the use of PD in special groups of ESRD patients and in a variety of non-uraemic conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Registration Committee of the European Dialysis and Tran-plant Association. Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol 1980; 87: 839–5.

    Google Scholar 

  2. Hou S. Peritoneal dialysis and hemodialysis in pregnancy. Baillieres Clin Obstet Gynecol 1987; 1: 1009–25.

    CAS  Google Scholar 

  3. Hou S. Pregnancy in women requiring dialysis for renal failure. Am J Kidney Dis 1987; 9: 368–73.

    PubMed  CAS  Google Scholar 

  4. Lavoie SD, Johnson-Whittaker L, Huard PJ et al. Two successful pregnancies on CAPD. Adv Petit Dial 1988; 4: 90–5.

    Google Scholar 

  5. Gadallah MF, Ahmad B, Karubian F et al. Pregnancy in patients on chronic ambulatory peritoneal dialysis. Am J Kidney Dis 1992; 20: 407–410.

    PubMed  CAS  Google Scholar 

  6. Hou S. Pregnancy in continuous ambulatory peritoneal dialysis (CAPD) patients. Petit Dial Int 1990; 10: 201–4.

    CAS  Google Scholar 

  7. Redav M, Cherem L, Eliot J et al. Dialysis in the management of pregnant patients with renal insufficiency. Medicine 1988; 67: 199.

    Google Scholar 

  8. Hou S, Orlowski J, Pahl M et al. Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor. Am J Kidney Dis 1993; 21: 16–22.

    PubMed  CAS  Google Scholar 

  9. Nagiotte MP, Grundg HO. Pregnancy outcome in women requiring chronic hemodialysis. Obstet Gynecol 1988; 72: 456–9.

    Google Scholar 

  10. Barri YM, Al Furayh O, Quinibi WY et al. Pregnancy in women on regular hemodialysis. Dial Transplant 1991; 20: 652–6.

    Google Scholar 

  11. Fujimi S, Hori K, Mujemd C et al. Successful pregnancy and delivery in a patient following r Hu EPO therapy and on long-term dialysis. J Am Soc Nephrol 1990; 1: 397 (abstract).

    Google Scholar 

  12. Okundaye I, Hou S. Results of pregnancy in patients undergoing dialysis. J Am Soc Nephrol 1995; 6: 398 (abstract).

    Google Scholar 

  13. Hou S. Pregnancy in women treated with peritoneal dialysis: viewpoint 1996. Petit Dial Int 1996; 16: 442–3.

    CAS  Google Scholar 

  14. Okundaye I, Hou S. Management of pregnancy in women undergoing ambulatory peritoneal dialysis. Adv Petit Dial 1996; 12: 151–5.

    CAS  Google Scholar 

  15. Jungers P, Chauveau D. Pregnancy in renal disease. Kidney Int 1997; 52: 871–85.

    PubMed  CAS  Google Scholar 

  16. Bagon JA, Vernaeve H, De Muylder X, Lafontaine JJ, Martens J, Van Roost G. Pregnancy and dialysis. Am J Kidney Dis 1998; 31: 756–65.

    PubMed  CAS  Google Scholar 

  17. Okundaye I, Abrinko P, Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis 1998; 31: 766–73.

    PubMed  CAS  Google Scholar 

  18. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999; 33: 235–52.

    PubMed  CAS  Google Scholar 

  19. Buehler N, Schreiber M, Moodley SJ et al. Successful pregnancy with APD. Petit Dial Int 1997; 17: S57 (abstract).

    Google Scholar 

  20. Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987; 316: 1062–8.

    PubMed  CAS  Google Scholar 

  21. Gardenswartz MH, Lerau CW, Seligson AR et al. Renal disease in patients with AIDS: a clinicopathological study. Clin Nephrol 1984; 21: 197–204.

    PubMed  CAS  Google Scholar 

  22. Nochy D, Glotz D, Dosquet P et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 1993; 8: 11–19.

    PubMed  CAS  Google Scholar 

  23. Laradi A, Mallet A, Beaufils H, Allouach M, Martinez F. HIV-associated nephropathy: outcome and prognosis factors. J Am Soc Nephrol 1998; 9: 2327–35.

    PubMed  CAS  Google Scholar 

  24. Humphreys MH. Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 1995; 48: 311–20.

    PubMed  CAS  Google Scholar 

  25. Ifudu O, Mayers JD, Matthew JJ et al. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s? Am J Kidney Dis 1997; 29: 549–52.

    PubMed  CAS  Google Scholar 

  26. Breen C, Stein A, Hendry B. Outcome for patients with HIV-associated nephropathy on dialysis in the UK. J Am Soc Nephrol 1998; 9: 201A (abstract).

    Google Scholar 

  27. Perinbasekar S, Brod-Miller C, Pal S, Mattara J. Predictors of survival in HIV-infected patients on hemodialysis. Am J Nephrol 1996; 16: 280–6.

    PubMed  CAS  Google Scholar 

  28. Cruz C, Kaul R, Markowitz N. Dialysis options for HIV infected patients. Petit Dial Int 1989; 9 (Suppl. 1): 89.

    Google Scholar 

  29. Graham MM, Bonini LA, Verdi MM. A multi-center study: clinical practices of HIV infected patients on CAPD/CCPD. Adv Petit Dial 1990; 3: 88–91.

    Google Scholar 

  30. Drissler R, Peters AT, Lynn RI. Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 1989; 86: 787–90.

    Google Scholar 

  31. Lewis M, Gorban-Brennan NL, Kliger A et al. Incidence and spectrum of organisms causing peritonitis in HIV positive patients on CAPD. Adv CAPD 1990; 6: 136–8.

    CAS  Google Scholar 

  32. Wasser WG, Beryl MJ, Brandons et al. HIV positivity does not predispose peritoneal dialysis patients to peritonitis. J Am Soc Nephrol 1991; 2: 369–73.

    Google Scholar 

  33. Schloth T, Genabe I, Pilgrim W et al. Peritonitis and the patient with human immunodeficiency virus (HIV). Adv Petit Dial 1992; 8: 250–2.

    CAS  Google Scholar 

  34. Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 1993; 43: 191–8.

    Google Scholar 

  35. Wasser WG, Bajl MJ, Brandon S et al. HIV positivity does not predispose peritoneal dialysis patients to peritonitis. Petit Dial Int 1993; 13 (Suppl. 1): S88 (abstract).

    Google Scholar 

  36. Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 1993; 44: 373–8.

    PubMed  CAS  Google Scholar 

  37. Scheel, Jr. PJ, Farzadegan H, Ford D, Malan M, Watson A. Recovery of human immunodeficiency virus from peritoneal dialysis effluent. J Am Soc Nephrol 1995; 5: 1926–9.

    PubMed  Google Scholar 

  38. Centre for Disease Control. Recommendations for providing dialysis treatment for patients infected with human-T-lymphotrophics virus type III/lymphadenopathy related virus. Ann Intern Med 1986; 106: 558–9.

    Google Scholar 

  39. MMWR. Recommendations for Prevention of HIV Transmission in Health Care Settings. 21 August 1987; 36: 25–185.

    Google Scholar 

  40. Chapman A, Wilkinson V, Peers EM, Brown CB. Intraperitoneal access for the treatment of peritonitis with AIDS. Petit Dial Int 1999; 19: S83 (abstract).

    Google Scholar 

  41. Wilkinson SP, Weston MJ, Parsons V et al. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 1977; 8: 287–92.

    PubMed  CAS  Google Scholar 

  42. Marcus RG, Messana J, Swartz R. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 1992; 93: 35–40.

    PubMed  CAS  Google Scholar 

  43. Durand P-Y, Friedd P, Chanleau J et al. Long term follow up in cirrhotic patients with chronic renal failure undergoing CAPD. Petit Dial Int 1993; 13 (Suppl. 1): S47 (abstract).

    Google Scholar 

  44. Horie M, Kobayashi S. Nezassa S et al. A case report of hepatic cirrhosis with ascites and uremia treated by CAPD. Petit Dial Int 1993; 13 (Suppl. 1): S73 (abstract).

    Google Scholar 

  45. Macia M, del Castillo N, Pulido-Duque J, Garcia J. Successful maintenance CAPD in a diabetic patient with ascites and cavernous transformation of the portal vein. Petit Dial Int 1996; 16: 533–5.

    CAS  Google Scholar 

  46. Dadone C, Pincella G, Bonoldi G et al. Transport of water and solutes in uremic patients with chronic hepatic disease in CAPD. Adv Petit Dial 1990; 6: 23–5.

    CAS  Google Scholar 

  47. Steiner RW. Continuous equilibration peritoneal dialysis in acute renal failure. Petit Dial Int. 1989; 9: 5–7.

    CAS  Google Scholar 

  48. Cameron JS, Ogg CH, Trounce JR. Peritoneal dialysis in hypercatabolic acute renal failure. Lancet 1967; 1: 1188–91.

    PubMed  CAS  Google Scholar 

  49. Posen GA, Luisello J. Continuous equilibration peritoneal dialysis in the treatment of acute renal failure. Petit Dial Bull 1981; 1: 6.

    Google Scholar 

  50. Katirtzoglous A, Kontesis P, Myopoulou-Symvoulidis D et al. Continuous equilibration peritoneal dialysis (CEPD) in hypercatabolic renal failure. Petit Dial Bull 1983; 3: 178–80.

    Google Scholar 

  51. Trevino-Becerra A, Munoz P, Avilez C et al. Equilibrium peritoneal dialysis (EPD) in acute renal failure (ARF) secondary to rhabdiomyolysis (sic). Petit Dial Bull 1987; 7: 244–6.

    Google Scholar 

  52. Siemons L, van den Heuvel P, Parizel G et al. Peritoneal dialysis in acute renal failure due to cholesterol embolization: two cases of recovery of renal function and extended survival. Clin Nephrol 1987; 28: 205–8.

    PubMed  CAS  Google Scholar 

  53. Nolph KD. Peritoneal dialysis for acute renal failure. Trans Am Soc Artif Intern Organs 1988; 34: 54–5.

    CAS  Google Scholar 

  54. Hamilton JW, Lasrich M, Hergil P. Peritoneal dialysis in the treatment of severe hypercalcemia. J Dial 1980; 4: 129–35.

    PubMed  CAS  Google Scholar 

  55. Heyburn PJ, Selby PL, Peacock M et al. Peritoneal dialysis in the management of severe hypercalcemia. Br Med J 1980; 280: 525–6.

    PubMed  CAS  Google Scholar 

  56. Querfelf U, Salusky IB, Fine RN. Treatment of severe hypercalcemia with peritoneal dialysis in an infant with end-stage renal disease. Pediatr Nephrol 1988; 2: 323–5.

    Google Scholar 

  57. Weinreich T, Ritz E, Passlick-Deetjen J. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Petit Dial Int 1996; 16: 260–8.

    CAS  Google Scholar 

  58. Thompson TJ, Neale TJ. Intraperitoneal calcium for resistant symptomatic hypocalcaemia after parathyroidectomy in chronic renal failure. Br Med J 1988; 296: 896–7.

    CAS  Google Scholar 

  59. Benz RL, Schleifer CR, Teehan BP et al. Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Petit Dial Int 1989; 9: 285–8.

    CAS  Google Scholar 

  60. Mailloux LU, Swartz CD, Onesti G et al. Peritoneal dialysis for refractory congestive heart failure. JAMA 1967; 199: 873–8.

    PubMed  CAS  Google Scholar 

  61. Nora JJ, Trygstad CW, Mangos JA et al. Peritoneal dialysis in the treatment of intractable congestive heart failure of infancy and childhood. J Pediatr 1966; 68: 693–8.

    PubMed  CAS  Google Scholar 

  62. Cairns KB, Porter GA, Kloster FE et al. Clinical and hemodynamic results of peritoneal dialysis for severe cardiac failure. Am Heart J 1968; 76: 227–34.

    PubMed  CAS  Google Scholar 

  63. Malach M. Peritoneal dialysis for intractable heart failure in acute myocardial infarction. Am J Cardiol 1972; 29: 61–3.

    PubMed  CAS  Google Scholar 

  64. Raja RM, Krasnoff SO, Moros JG et al. Repeated peritoneal dialysis in treatment of heart failure. JAMA 1970; 213: 2268–9.

    PubMed  CAS  Google Scholar 

  65. Shapira J, Lang R, Jutrin I et al. Peritoneal dialysis in refractory congestive heart failure. Part I: Intermittent peritoneal dialysis (IPD). Petit Dial Bull 1983; July-Sept: 130–2.

    Google Scholar 

  66. Weinrauch LA, Kaldany A, Miller DG et al. Cardiorenal failure: treatment of refractory biventricular failure by peritoneal dialysis. Uremia Invest 1984; 8: 1–8.

    PubMed  CAS  Google Scholar 

  67. Robson M, Biro A, Knobel B et al. Peritoneal dialysis in refractory congestive heart failure. Part II: Continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1983; July-Sept: 133–4.

    Google Scholar 

  68. McKinnie JJ, Bourgeois RJ, Husserl FE. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med 1985; 145: 1128–9.

    PubMed  CAS  Google Scholar 

  69. Kim D, Khanna R, Wu G et al. Successful use of continuous ambulatory peritoneal dialysis in refractory heart failure. Petit Dial Bull 1985: 127–30.

    Google Scholar 

  70. Rubin J, Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Arch Intern Med 1986; 146: 1533–5.

    PubMed  CAS  Google Scholar 

  71. Shilo S, Slotki IN, Iaina A. Improved renal function following acute peritoneal dialysis in patients with intractable congestive heart failure. Isr J Med Sci 1987; 23: 821–4.

    PubMed  CAS  Google Scholar 

  72. Mousson C, Tanter Y, Chalopin JM et al. Treatment of refractory congestive cardiac insufficiency by continuous ambulatory peritoneal dialysis. Long-term course. Presse Med 1988; 17: 1617–20.

    PubMed  CAS  Google Scholar 

  73. Konig PS, Lhotta K, Kronenberg F et al. CAPD: a successful treatment in patients suffering from therapy_resistant congestive heart failure. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Petit Dial Bull Inc., 1991; 7: 97–101.

    Google Scholar 

  74. Stegmayr BG, Banga R, Lundberg L, Wikdahl AN, PlumWirell M. PD treatment for severe congestive heart failure. Petit Dial Int 1996; 16: S231–5.

    Google Scholar 

  75. Ryckelynck J-P, Lobbedez T, Valette B, Le Goff C, Mazouz O, Levaltier B, Potier J-C, Hurault de Ligny B. Peritoneal ultrafiltration and refractory congestive heart failure. Adv Petit Dial 1997; 13: 93–7.

    CAS  Google Scholar 

  76. Burton BK. Inborn errors of metabolism: the clinical diagnosis in early infancy. Pediatrics 1987; 79: 359–69.

    PubMed  CAS  Google Scholar 

  77. Donn SM, Swartz RD, Thoene JG. Comparison of exchange transfusion, peritoneal dialysis and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 1979; 95: 67–70.

    PubMed  CAS  Google Scholar 

  78. Wiegand C, Thompson T, Bock GH et al. The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr 1980; 96: 142–4.

    PubMed  CAS  Google Scholar 

  79. Rutledge SL, Havens PL, Haymond MW et al. Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr 1990; 116: 125–8.

    PubMed  CAS  Google Scholar 

  80. Siegel NJ, Brown RS. Peritoneal clearance of ammonia and creatinine in a neonate. J Pediatr 1973; 82: 1044–6.

    PubMed  CAS  Google Scholar 

  81. Lettgen B, Bonze] KE, Colombo JP et al. Therapy of hyperammonemia in carbamyl phosphate synthase deficiency with peritoneal dialysis and venovenous hemofiltration. Monatsschr Kinderheilkd 1991; 139: 612–7.

    PubMed  CAS  Google Scholar 

  82. Russell G, Thom H, Tarlow MJ et al. Reduction of plasma propionate by peritoneal dialysis. Pediatrics 1974; 53: 281–3.

    PubMed  CAS  Google Scholar 

  83. Hsu WC, Lin SP, Huang FY et al. Propionic acidemia: report of a case that is successfully managed by peritoneal dialysis and sodium benzoate therapy. Chin Med J 1990; 46: 306–10.

    CAS  Google Scholar 

  84. Robert MF, Schultz DJ, Wolf B et al. Treatment of a neonate with propionic acidaemia and severe hyperammonemia by peritoneal dialysis. Arch Dis Child 1979; 54: 962–5.

    PubMed  CAS  Google Scholar 

  85. Gortner L, Leupold D, Pohlandt F et al. Peritoneal dialysis in the treatment of metabolic crises caused by inherited disorders of organic and amino acid metabolism. Acta Paediats Scand 1989; 78: 706–11.

    CAS  Google Scholar 

  86. Sanjurjo P, Jaquotot C, Vallo A et al. Combined exchange transfusion and peritoneal dialysis treatment in a neonatal case of methylmalonic acidemia with severe hyperammonemia. An Esp Pediatr 1982; 17: 317–20.

    PubMed  CAS  Google Scholar 

  87. Moreno-Vega A, Govantes JM. Methylmalonic acidemia treated by continuous ambulatory peritoneal dialysis (letter). N Engl J Med 1985; 312: 1641–2.

    PubMed  CAS  Google Scholar 

  88. McMahon Y, MacDonnell RC Jr. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Petit Dial Bull Inc., 1990; 6: 31–4.

    Google Scholar 

  89. Sallan SE, Cottom D. Peritoneal dialysis in maple syrup urine disease. Lancet 1969; 635: 1423–4.

    Google Scholar 

  90. Clow CL, Reade TM, Scriver CR. Outcome of early and long-term management of classical maple syrup urine disease. Pediatrics 1981; 68: 856–62.

    PubMed  CAS  Google Scholar 

  91. Vandepitte K, Lins RL, Daelemans R et al. Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency. Petit Dial Int 1989; 9: 111–14.

    CAS  Google Scholar 

  92. Bunchman TE, Swartz RD. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD. Petit Dial Int 1994; 14: 81–4.

    CAS  Google Scholar 

  93. Lankisch PG, Koop H, Winckler K et al. Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the rat. II: analysis of its beneficial effect. Dig Dis Sci 1979; 24: 117–22.

    PubMed  CAS  Google Scholar 

  94. Wall AJ. Peritoneal dialysis in the treatment of severe acute pancreatitis. Med J Aust 1965; 2: 281–3.

    PubMed  CAS  Google Scholar 

  95. Rasmussen BL. Hypothermic peritoneal dialysis in the treatment of acute experimental hemorrhagic pancreatitis. Am J Surg 1967; 114: 716–21.

    PubMed  CAS  Google Scholar 

  96. Bassi C, Briani G, Vesentini S et al. Continuous peritoneal dialysis in acute experimental pancreatitis in dogs. Effect of aprotinin in the dialysate medium. Int J Pancreatol 1989; 5: 69–75.

    PubMed  CAS  Google Scholar 

  97. Lankisch PG, Koop H, Winckler K et al. Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the rat. I: Effect on length and rate of survival. Dig Dis Sci 1979; 24: 111–16.

    PubMed  CAS  Google Scholar 

  98. Tilquin BM, O’Connor TC, Hancotte-LaHaye CM et al. The effect of peritoneal dialysis with and without aprotinin on acute experimental pancreatitis in rats. Int Surg 1990; 75: 174–8.

    PubMed  CAS  Google Scholar 

  99. Fric P, Slaby J, Kosafirek E et al. Effective peritoneal therapy of acute pancreatitis in the rat with glutaryl-trialanin-ethylamide: a novel inhibitor of pancreatic elastase. Gut 1992; 33: 701–6.

    PubMed  CAS  Google Scholar 

  100. Ranson JHC, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 1976; 143: 209–19.

    PubMed  CAS  Google Scholar 

  101. Ranson JHC, Spencer FC. The role of peritoneal lavage in severe acute pancreatitis. Ann Surg 1978; 187: 565–75.

    PubMed  CAS  Google Scholar 

  102. Ranson JHC, Berman RS. Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis. Ann Surg 1990; 211: 708–18.

    PubMed  CAS  Google Scholar 

  103. Stone HH, Fabian TC. Peritoneal dialysis in the treatment of acute alcoholic pancreatitis. Surg Gynecol Obstet 1980; 150: 878–82.

    PubMed  CAS  Google Scholar 

  104. Mayer AD, McMahon MJ, Corfield AP et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. NEJM 1985; 312: 399–404.

    PubMed  CAS  Google Scholar 

  105. Crist DW, Cameron JL. The current management of acute pancreatitis. Adv Surg 1987; 20: 69–123.

    PubMed  CAS  Google Scholar 

  106. Joglar FM, Saadé M. Outcome and pancreatitis in CAPD and HD patients. Petit Dial Int 1995; 15: 264–73.

    CAS  Google Scholar 

  107. Ubara Y, Hara S, Katori H et al. Acute pancreatitis in a CAPD patient in association with hemolytic anemia. Petit Dial Int 1997; 17: 96–7.

    CAS  Google Scholar 

  108. Donnelly S, Levy M, Prichard S. Acute pancreatitis in continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Int 1988; 8: 187–90.

    Google Scholar 

  109. Gupta A, Yi Yuan Z, Balaskas EV, Khanna R, Oreopoulos DG. CAPD and pancreatitis: no connection. Petit Dial Int 1992; 12: 309–16.

    CAS  Google Scholar 

  110. Moncade F, Fortier A, Guyon P et al. Peritoneal puncture dialysis in the monitoring and treatment of hemoperitoneum of traumatic origin? J Chir 1991; 128 (6_7): 285–9.

    CAS  Google Scholar 

  111. Delaitre B, Attailia A, Chibaoui M. Perforated gastroduodenal ulcers. Treatment by peritoneal dialysis. 72 cases. Presse Med 1988; 17: 1297–300.

    PubMed  CAS  Google Scholar 

  112. McEvoy J, Kelly AMT. Psoriatic clearance during hemodialysis. Ulster Med J 1976; 45: 76–8.

    PubMed  CAS  Google Scholar 

  113. Twardowski ZJ. Abatement of psoriasis and repeated dialysis (letter). Ann Intern Med 1977; 86: 509–10.

    Google Scholar 

  114. Twardowski ZJ, Nolph KD, Rubin J et al. Peritoneal dialysis for psoriasis. An uncontrolled study. Ann Intern Med 1978; 88: 345–51.

    Google Scholar 

  115. Hanicki Z, Cichocki T, Klein A et al. Dialysis for psoriasis–preliminary remarks concerning mode of action. Arch Dermatol Res 1981; 271: 401–5.

    PubMed  CAS  Google Scholar 

  116. Goring HD, Thieler H, Guldner G et al. Peritoneal dialysis therapy in psoriasis. Hautarzt 1981; 32: 173–8.

    PubMed  CAS  Google Scholar 

  117. Halevy S, Halevy J, Boner G et al. Dialysis therapy for psoriasis. Report of three cases and review of the literature. Arch Dermatol 1981; 117: 69–72.

    PubMed  CAS  Google Scholar 

  118. Kramer P, Brunner FP, Brynger H et al. Dialysis treatment and psoriasis in Europe. Clin Nephrol 1982; 18: 62–8.

    PubMed  CAS  Google Scholar 

  119. Whittier FC, Evans DH, Anderson PC et al. Peritoneal dialysis for psoriasis: a controlled study. Ann Intern Med 1983; 99: 165–8.

    PubMed  CAS  Google Scholar 

  120. Glinski W, Jablonska S, Imiela J et al. Peritoneal dialysis and leukopheresis in psoriasis: indications and contraindications. Hautarzt 1985; 36: 16–19.

    PubMed  CAS  Google Scholar 

  121. Twardowski ZJ, Lempert KD, Lankhorst BJ et al. Continuous ambulatory peritoneal dialysis for psoriasis. A report of four cases. Arch Intern Med 1986; 146: 1177–9.

    PubMed  CAS  Google Scholar 

  122. Sobh MA, Abdel Rasik MM, Moustafa FE et al. Dialysis therapy of severe psoriasis: a random study of forty cases. Nephrol Dial Transplant 1987; 2: 351–8.

    PubMed  CAS  Google Scholar 

  123. Nissenson AR, Rapaport M, Gordon A et al. Hemodialysis in the treatment of psoriasis: a controlled trial. Ann Intern Med 1979; 91: 218–20.

    PubMed  CAS  Google Scholar 

  124. Goldsmith LA, Fisher M, Wacks J. Psychological characteristics of psoriasis: implications for management. Arch Dermatol 1969; 100: 674.

    PubMed  CAS  Google Scholar 

  125. Anderson PC. Dialysis treatment of psoriasis (editorial). Arch Dermatol 1981; 117: 67–8.

    PubMed  CAS  Google Scholar 

  126. Chen WT, Hu CH, Schiltz JR et al. In search of `psoriasis factor(s)’: a new approach by extracorporeal treatment. Artif Organs 1978; 2: 203–5.

    PubMed  CAS  Google Scholar 

  127. Glinski W, Zarebska Z, Jablonska S et al. The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis. J Invest Dermatol 1980; 75: 481–7.

    PubMed  CAS  Google Scholar 

  128. Glinski W, Jablonska S, Imiela J et al. Peritoneal dialysis and leukopheresis in psoriasis: indications and contraindications. Hautarzt 1985; 36: 16–19.

    PubMed  CAS  Google Scholar 

  129. Krebs R, Flynn M. Treatment of hepatic coma with exchange transfusion and peritoneal dialysis. JAMA 1967; 199: 430–2.

    PubMed  CAS  Google Scholar 

  130. Pirola RC, Ham JC, Elmslie RG. Management of hepatic coma complicating viral hepatitis. Gut 1969; 10: 898–903.

    PubMed  CAS  Google Scholar 

  131. Mactier RA, Dobbie JW, Khanna R. Peritoneal dialysis in fulminant hepatic failure. Petit Dial Bull 1986; 6: 199–202.

    Google Scholar 

  132. Mactier R. Non-renal indications for peritoneal dialysis. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Petit Dial Bull Inc 1992.

    Google Scholar 

  133. Lash RF, Burdette JA, Ozdil T. Accidental profound hypothermia and barbiturate intoxication: a report of rapid `core’ rewarming by peritoneal dialysis. JAMA 1967; 201: 269–70.

    PubMed  CAS  Google Scholar 

  134. Reuler JB, Parker RA. Peritoneal dialysis in the management of hypothermia. JAMA 1978; 240: 2289–90.

    PubMed  CAS  Google Scholar 

  135. Moss JF, Haklin M, Southwick HW et al. A model for the treatment of accidental severe hypothermia. J Trauma 1986; 26: 68–74.

    PubMed  CAS  Google Scholar 

  136. DaVee TS, Reineberg EJ. Extreme hypothermia and ventricular fibrillation. Ann Emerg Med 1980; 9: 100–2.

    PubMed  CAS  Google Scholar 

  137. Davis FM, Judson JA. Warm peritoneal dialysis in the management of accidental hypothermia: report of five cases. NZ Med J 1981; 94: 207–9.

    CAS  Google Scholar 

  138. Troelsen S, Rybro L, Knudsen F. Profound accidental hypothermia treated with peritoneal dialysis. Scand J Urol Nephrol 1986; 20: 221–4.

    PubMed  CAS  Google Scholar 

  139. Horowitz BZ. The golden hour in heat stroke: use of iced peritoneal lavage. Am J Emerg Med 1989; 7: 616–19.

    PubMed  CAS  Google Scholar 

  140. Khan IH, Henderson IS, Mactier RA. Hyperpyrexia due to meningococcal septicaemia treated with cold peritoneal lavage. Postgrad Med J 1992; 68: 129–31.

    PubMed  CAS  Google Scholar 

  141. Blye E, Lorch J, Cortell S. Extracorporeal therapy in the treatment of intoxication. Am J Kidney Dis 1984; 3: 321–38.

    PubMed  CAS  Google Scholar 

  142. Schlegel RJ, Altstatt LB, Canales L et al. Peritoneal dialysis for severe salicylism: an evaluation of indications and results. J Pediatr 1966; 69: 553–62.

    PubMed  CAS  Google Scholar 

  143. Arieff AI, Friedman EA. Coma following nonnarcotic drug overdosage: management of 208 adult patients. Am J Med Sci 1973; 266: 405–26.

    PubMed  CAS  Google Scholar 

  144. Pross DC, Bradford WD, Krueger RP. Reye’s syndrome treated by peritoneal dialysis. Pediatrics 1970; 45: 845.

    Google Scholar 

  145. Shaw EB. Reye’s syndrome and salicylate intoxication. Pediatrics 1970; 46: 976–7.

    Google Scholar 

  146. Narcy P, Zorza G, Taburet AM et al. Severe poisoning with intravenous phenytoin in the newborn. Value of peritoneal dialysis. Arch Fran Pediatr 1990; 47: 591–3.

    CAS  Google Scholar 

  147. Roger SD, Crimmins D, Yiannikas C et al. Lead intoxication in an anurie patient: management by intraperitoneal EDTA. Aust NZ J Med 1990; 20: 814–17.

    CAS  Google Scholar 

  148. Dua SL. Peritoneal dialysis for isopropyl alcohol poisoning (letter). JAMA 1974; 230: 35.

    PubMed  CAS  Google Scholar 

  149. Kaufman DB, DiNicola W, McIntosh R. Acute potassium dichromate poisoning. Treated by peritoneal dialysis. Am J Dis Child 1970; 119: 374–6.

    PubMed  CAS  Google Scholar 

  150. Lichtenberg R, Zeller WP, Gatson R et al. Bromate poisoning. J Pediatr 1989; 114: 891–4.

    PubMed  CAS  Google Scholar 

  151. Warshaw BL. Treatment of bromate poisoning. J Pediatr 1989; 115: 660–1.

    PubMed  CAS  Google Scholar 

  152. Duo LJ, Zhi ZG, Ji LY. Peritoneal dialysis in the treatment of severe poisoning with organophosphorus pesticides: experience with twenty-two patients. Petit Dial Int 1990; 10: 242–3.

    CAS  Google Scholar 

  153. Kassa J. Use of peritoneal dialysis as a therapeutic method in poisoning by Neguvon. Cesko Farm 1990; 39: 7–10.

    CAS  Google Scholar 

  154. Yamamoto Y, Wakisaka O, Fujimoto S et al. Acute renal failure caused by ingestion of the carp gall bladder–a report of 3 cases, with special reference to the reported cases in Japan. J Jap Soc Intern Med 1988; 77: 1268–73.

    CAS  Google Scholar 

  155. Yium J, Martinez-Maldonado M, Eknoyan G et al. Peritoneal dialysis in the treatment of renal failure in multiple myeloma. South Med J 1971; 64: 1403–5.

    PubMed  CAS  Google Scholar 

  156. Russell JA, Fitzharris BM, Corringham R et al. Plasma exchange versus peritoneal dialysis for removing Bence Jones protein. Br Med J 1978; 2: 1397.

    PubMed  CAS  Google Scholar 

  157. Rosansky SJ, Richards FW. Use of peritoneal dialysis in the treatment of patients with renal failure and paraproteinemia. Am J Nephrol 1985; 5: 361–5.

    PubMed  CAS  Google Scholar 

  158. Rose PE, McGonigle R, Michael J et al. Renal failure and the histopathological features of myeloma kidney reversed by intensive chemotherapy and peritoneal dialysis. Br Med J 1987; 294: 411–12.

    CAS  Google Scholar 

  159. Boyce NW, Holdsworth SR, Thomson NM et al. ‘Longterm’ survival in light-chain myeloma with dialysis therapy alone. Aust NZ J Med 1984; 14: 676–7.

    CAS  Google Scholar 

  160. Cosio FG, Pence RV, Shapiro FL et al. Severe renal failure in multiple myeloma. Clin Nephrol 1981; 15: 206–10.

    PubMed  CAS  Google Scholar 

  161. Brown WW, Herbert LA, Piering WF et al. Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med 1979; 90: 793–4.

    PubMed  CAS  Google Scholar 

  162. Johnson WJ, Kyle RA, Dahlberg PJ. Dialysis in the treatment of multiple myeloma. Mayo Clin Proc 1980; 55: 65–72.

    PubMed  CAS  Google Scholar 

  163. Shetty A, Oreopoulos DG. Continuous ambulatory peritoneal dialysis in end-stage renal disease due to multiple myeloma. Petit Dial Int 1995; 15: 236–40.

    CAS  Google Scholar 

  164. Misra M, Goel S, Khanna R. Peritoneal dialyssi in patients with abdominal vascular prostheses. Adv Petit Dial 1998; 14: 95–7.

    CAS  Google Scholar 

  165. Vogt, J, Chlebowski H, Kniemeyer H-W, Grabensee B. Successful reinstitution of CAPD after retroperitoneal repair of an aortic aneurysm: a case report. Petit Dial Int 1995; 15: 71–2.

    CAS  Google Scholar 

  166. Goodship THJ, Lloyd S, McKenzie PW et al. Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1987; 73: 471–8.

    PubMed  CAS  Google Scholar 

  167. Oreopoulos DG, Marliss EB, Anderson GH et al. Nutritional aspects of CAPD and the potential use of amino acid containing dialysis solutions. Petit Dial Bull 1983 (Suppl. 3 ): 510–12.

    Google Scholar 

  168. Mitwalli A, Rodella H, Brandes L et al. Is fat absorbed through the peritoneum? Petit Dial Bull 1985; 5: 165–8.

    Google Scholar 

  169. Pessa ME, Sitren HS, Copeland EM III et al. Nutritional support by intraperitoneal dialysis in the rat: maintenance of body weight with normal liver and plasma chemistries. J Parent Ent Nutr 1988; 12: 63–7.

    CAS  Google Scholar 

  170. Siriwardhana SA, Newfield AM, Lipton JM et al. Oxygen delivery by the peritoneal route. Can J Anesthes 1990; 37: 5159.

    Google Scholar 

  171. Shah BS. An in vitro model for chemical extraction of carbon dioxide via modified peritoneal dialysis. ASAIO Trans 1988; 34: 112–15.

    PubMed  CAS  Google Scholar 

  172. Hoff CM, Shockley TR. The potential of gene therapy in the peritoneal cavity. Petit Dial Int 1999; 19 (Suppl. 2): in press.

    Google Scholar 

  173. Hoff CM, Cusick JL, Masse EM, Jackman RW, Nagy JA, Shockley TR. Modulation of transgene expression in mesothelial cells by activation of an inducible promoter. Nephrol Dial Transplant 1998; 13: 1420–4.

    PubMed  CAS  Google Scholar 

  174. Jackman RW, Stapleton TD, Masse EM et al. Enhancement of the functional repertoire of the rat parietal peritoneal mesothelium In vivo: directed expression of the anticoagulant and antiinflammatory molecule thrombomodulin. Human Gene Therapy 1998; 9: 1069–81.

    PubMed  CAS  Google Scholar 

  175. Hoff CM, Shockley TR. Genetic modification of the peritoneal membrane: potential for improving peritoneal dialysis through gene therapy. Semin Dial 1998; 11: 218–27.

    Google Scholar 

  176. Nagy JA, Shockley TR, Masse EM, Harvey VS, Hoff CM, Jackman RW. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Therapy 1995; 2: 402–10.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Prichard, S.S., Bargman, J.M. (2000). The use of peritoneal dialysis in special situations. In: Gokal, R., Khanna, R., Krediet, R.T., Nolph, K.D. (eds) Textbook of Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-3225-3_24

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-3225-3_24

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-3227-7

  • Online ISBN: 978-94-017-3225-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics